A Study to evaluate the effect of Matulungadi Vati in reducing nausea and vomiting in pregnant women

An Open Label Randomized Controlled Clinical Study To Evaluate The Effect Of Matulungadi Vati In Management Of Garbhini Chardi Vis-a-vis Emesis Gravidarum - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104372

Enrollment

Registered

2026-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O219- Vomiting of pregnancy, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women aged 21 to 35 years First trimester of pregnancy less than or equal to 12 weeks gestation Symptoms of nausea and or vomiting not exceeding more than 5 episodes per day Willing to participate in the study

Exclusion criteria

Exclusion criteria: Known Case Of Hyperemesis gravidarum Known Case Of Systemic illness or endocrine disorders Known Case Of Severe anemia less than 6g per dl Hepatic or Renal dysfunction Known Case Of High Risk Pregnancy Diagnosed Multiple gestation Use of any antiemetic drugs in past 48 hours

Design outcomes

Primary

Measure	Time frame
Reduction in severity and frequency of nausea and vomiting in pregnant women assessed using visual analogue scale and PUQE 24 scoring systemTimepoint: baseline day 0 and end of the treatment day 7	—

Secondary

Measure	Time frame
NilTimepoint:	—

Countries

India

Contacts

Public ContactDr Usha DT

JSS Ayurveda Medical College and Hospital

Usha.ayurveda@gmail.com9164455019

Outcome results